Hudson Bay Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Hudson Bay Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41M	Buy	+275,000	New	+$4.55M	0.01%	600
2025 Q2	–	Sell	-227,500	Closed	-$3.38M	–	1647
2025 Q1	$3.38M	Sell	227,500 -47,500	-17%	-$666K	0.01%	697
2024 Q4	$3.64M	Buy	275,000 +25,000	+10%	+$343K	0.01%	559
2024 Q3	$3.56M	Sell	250,000 -100,000	-29%	-$1.42M	0.01%	490
2024 Q2	$4.53M	Buy	350,000 +175,000	+100%	+$2.32M	0.02%	396
2024 Q1	$2.43M	Hold	175,000	–	–	0.01%	425
2023 Q4	$2.5M	Buy	+175,000	New	+$2.48M	0.02%	412
2022 Q4	–	Sell	-130,000	Closed	-$1.69M	–	1107
2022 Q3	$1.69M	Buy	130,000 +10,000	+8%	+$139K	0.01%	771
2022 Q2	$1.69M	Sell	120,000 -95,000	-44%	-$1.36M	0.01%	839
2022 Q1	$3.08M	Sell	215,000 -50,000	-19%	-$734K	0.04%	560
2021 Q4	$3.61M	Buy	265,000 +80,000	+43%	+$1.12M	0.04%	483
2021 Q3	$3.03M	Buy	185,000 +10,000	+6%	+$168K	0.04%	519
2021 Q2	$2.94M	Buy	+175,000	New	+$2.98M	0.04%	522
2020 Q1	–	Sell	-548,068	Closed	-$10.8M	–	575
2019 Q4	$10.8M	Sell	548,068 -601,693	-52%	-$11.5M	0.24%	74
2019 Q3	$19.8M	Buy	1,149,761 +87,231	+8%	+$1.51M	0.55%	36
2019 Q2	$18.8M	Buy	1,062,530 +432,192	+69%	+$7.86M	0.43%	41
2019 Q1	$12.8M	Buy	630,338 +614,590	+3,903%	+$12.4M	0.17%	120
2018 Q4	$265K	Buy	+15,748	New	+$266K	﹤0.01%	724

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Hudson Bay Capital Management's TAK Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 275,000 shares worth $4.41M. The stake represents 0.01% of the portfolio and ranks #600 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in TAK as recently as Q1 2025.

Hudson Bay Capital Management first reported a position in TAK in Q4 2018 and has held it in 18 quarters since. The position peaked at $19.8M in Q3 2019. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Hudson Bay Capital Management held 275,000 shares of Takeda Pharmaceutical worth $4.41M as of Q2 2026.
Takeda Pharmaceutical was a new Hudson Bay Capital Management position in Q2 2026.
Takeda Pharmaceutical made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #600 holding.
Hudson Bay Capital Management first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 18 quarters since.
Hudson Bay Capital Management's Takeda Pharmaceutical position peaked at $19.8M in Q3 2019.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.